eslicarbazepine acetate has been researched along with Depression in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Arafa, MF; Dorgham, EM; El Maghraby, GM; Essa, EA | 1 |
| Agredano, PM; Bayarri, PG; Bermejo, PE; Campos, D; Falip, M; García-Morales, I; Gil-Nagel, A; Giráldez, BG; Gomariz, EL; González, FJL; Jiménez-Huete, A; Jovel, CE; Navacerrada, FJ; Ojeda, J; Palao, S; Pascual, MRQ; Prior, MJAA; Sáez, AA; Toledano, R | 1 |
| Andermann, E; Ben-Menachem, E; Benbadis, SR; Biraben, A; Biton, V; Blum, D; Carreño, M; Cheng, H; Gama, H; Rocha, F; Shah, AK; Shneker, B; Trinka, E | 1 |
| Assenza, F; Assenza, G; Di Lazzaro, V; Lanzone, J; Mecarelli, O; Pulitano, P; Tombini, M | 1 |
| Abraira, L; Ortega, G; Quintana, M; Salas-Puig, J; Sanabria, A; Santamarina, E; Toledo, M | 1 |
| Blum, D; Cheng, H; Chung, S; Grinnell, T; Jung, J; Shah, A; Sinha, SR; Stern, JM | 1 |
| Cimadevilla, JM; Fernández-Pérez, J; Payán-Ortiz, M; Quiroga-Subirana, P; Serrano-Castro, PJ | 1 |
1 review(s) available for eslicarbazepine acetate and Depression
| Article | Year |
|---|---|
Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Clinical Trials, Phase III as Topic; Cognitive Dysfunction; Depression; Depressive Disorder; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Seizures; Treatment Outcome | 2018 |
3 trial(s) available for eslicarbazepine acetate and Depression
| Article | Year |
|---|---|
[Social cognition and cognitive functions in patients with epilepsy treated with eslicarbazepine acetate].
Topics: Adult; Anticonvulsants; Anxiety; Cognition; Depression; Dibenzazepines; Dose-Response Relationship, Drug; Emotional Intelligence; Epilepsies, Partial; Executive Function; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Quality of Life; Theory of Mind; Verbal Learning | 2018 |
Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Depression; Dibenzazepines; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Longitudinal Studies; Male; Middle Aged; Quality of Life; Seizures; Treatment Outcome; Young Adult | 2019 |
[Eslicarbazepine acetate in clinical practice. Efficacy and safety results].
Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Cognition Disorders; Depression; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Lacosamide; Male; Middle Aged; Sodium Channel Blockers; Weight Gain; Young Adult | 2013 |
3 other study(ies) available for eslicarbazepine acetate and Depression
| Article | Year |
|---|---|
Melting point depression for enhanced dissolution rate of eslicarbazepine acetate.
Topics: Calorimetry, Differential Scanning; Citric Acid; Depression; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2022 |
Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Depression; Dibenzazepines; Dizziness; Female; Headache; Humans; Male; Middle Aged; Prospective Studies; Seizures; Spain; Treatment Outcome; Young Adult | 2017 |
The ROME (Retrospective Observational Multicenter study on Eslicarbazepine) study: Efficacy and behavioural effects of Eslicarbazepine acetate as adjunctive therapy for adults with partial onset seizures in real life.
Topics: Anticonvulsants; Antidepressive Agents; Depression; Dibenzazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quality of Life; Retrospective Studies; Seizures; Sleep; Treatment Outcome; Wakefulness-Promoting Agents | 2018 |